-transparent.png){kind=logo}
For comparative study of the pharmacokinetics of Cemidexor (capsules of 100 mg) and Suprax (capsules of 400 mg), a method of HPLC with quantitative determination of cefixime (the active substance in the drugs) in the blood plasma of patients with UV detection was developed. The data teproducibility with an account of the admissibility criterion was observed within the interval of all the concentrations (0.06-10 mcg/ml). The accuracy and correctness of the method also corresponded to the admissibility criteria. The lower limit of the quantitative determimation of the cefexime blood plasma levels was 0.06 mcg/ml. The pharmacokinetics was studied with the open crossed randomized method. The results were used for calculation of the pharmacokinetic parameters required for estimation of the bioequivalence of the drugs. The statistical analysis of the pharmacokinetic parameters showed that Cemidoxor and Suprax were bioequivalent.
V V Pisarev, and
K V Zaĭtseva, and
L B Smirnova, and
V G Belolipetskaia, and
D A Kibal'chich, and
I E Koltunov
January 1982,
Bollettino chimico farmaceutico,
V V Pisarev, and
K V Zaĭtseva, and
L B Smirnova, and
V G Belolipetskaia, and
D A Kibal'chich, and
I E Koltunov
January 2002,
Postepy biochemii,
V V Pisarev, and
K V Zaĭtseva, and
L B Smirnova, and
V G Belolipetskaia, and
D A Kibal'chich, and
I E Koltunov
November 1991,
Die Pharmazie,
V V Pisarev, and
K V Zaĭtseva, and
L B Smirnova, and
V G Belolipetskaia, and
D A Kibal'chich, and
I E Koltunov
October 1987,
Recenti progressi in medicina,
V V Pisarev, and
K V Zaĭtseva, and
L B Smirnova, and
V G Belolipetskaia, and
D A Kibal'chich, and
I E Koltunov
April 1993,
Bollettino chimico farmaceutico,
V V Pisarev, and
K V Zaĭtseva, and
L B Smirnova, and
V G Belolipetskaia, and
D A Kibal'chich, and
I E Koltunov
January 1986,
Bollettino chimico farmaceutico,
V V Pisarev, and
K V Zaĭtseva, and
L B Smirnova, and
V G Belolipetskaia, and
D A Kibal'chich, and
I E Koltunov
September 2000,
Analytical chemistry,
V V Pisarev, and
K V Zaĭtseva, and
L B Smirnova, and
V G Belolipetskaia, and
D A Kibal'chich, and
I E Koltunov
July 1995,
Journal of pharmaceutical and biomedical analysis,
V V Pisarev, and
K V Zaĭtseva, and
L B Smirnova, and
V G Belolipetskaia, and
D A Kibal'chich, and
I E Koltunov
March 2013,
Journal of basic and clinical pharmacy,
V V Pisarev, and
K V Zaĭtseva, and
L B Smirnova, and
V G Belolipetskaia, and
D A Kibal'chich, and
I E Koltunov
January 1989,
Free radical biology & medicine,
